Infinity Pharmaceuticals Inc (INFIQ)
0.0000
USD |
OTCM |
May 03, 14:59
Infinity Pharmaceuticals Total Liabilities (Quarterly): 58.64M for June 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | 58.64M |
March 31, 2023 | 58.27M |
December 31, 2022 | 61.20M |
September 30, 2022 | 62.46M |
June 30, 2022 | 62.96M |
March 31, 2022 | 62.60M |
December 31, 2021 | 63.21M |
September 30, 2021 | 62.47M |
June 30, 2021 | 61.06M |
March 31, 2021 | 60.35M |
December 31, 2020 | 62.31M |
September 30, 2020 | 61.09M |
June 30, 2020 | 60.04M |
March 31, 2020 | 59.34M |
December 31, 2019 | 41.29M |
September 30, 2019 | 40.49M |
June 30, 2019 | 38.87M |
March 31, 2019 | 35.34M |
December 31, 2018 | 7.756M |
September 30, 2018 | 6.141M |
June 30, 2018 | 5.71M |
March 31, 2018 | 4.569M |
December 31, 2017 | 11.62M |
September 30, 2017 | 10.90M |
June 30, 2017 | 31.94M |
Date | Value |
---|---|
March 31, 2017 | 29.82M |
December 31, 2016 | 43.20M |
September 30, 2016 | 49.78M |
June 30, 2016 | 68.46M |
March 31, 2016 | 178.85M |
December 31, 2015 | 190.26M |
September 30, 2015 | 199.62M |
June 30, 2015 | 153.62M |
March 31, 2015 | 146.56M |
December 31, 2014 | 159.67M |
September 30, 2014 | 151.31M |
June 30, 2014 | 27.10M |
March 31, 2014 | 26.73M |
December 31, 2013 | 29.44M |
September 30, 2013 | 30.55M |
June 30, 2013 | 27.82M |
March 31, 2013 | 24.13M |
December 31, 2012 | 25.46M |
September 30, 2012 | 18.46M |
June 30, 2012 | 116.44M |
March 31, 2012 | 107.96M |
December 31, 2011 | 109.06M |
September 30, 2011 | 69.63M |
June 30, 2011 | 66.42M |
March 31, 2011 | 65.89M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
38.87M
Minimum
Jun 2019
63.21M
Maximum
Dec 2021
57.45M
Average
61.06M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
Athersys Inc | 43.82M |
Merck & Co Inc | 69.04B |
MEI Pharma Inc | 19.05M |
Humanigen Inc | 54.84M |
Bristol-Myers Squibb Co | 82.48B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 21.23M |
Shareholders Equity (Quarterly) | -37.41M |
Current Ratio | 1.650 |